noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

Dogecoin Cash Inc.

Notice of Proposed Sale of Securities (Form 144)
City of Portland, OR

South Waterfront update: Roads reopen near ICE facility, new two-way[...]
City of Portland, OR

Governor Kotek, Attorney General Rayfield, Mayor Wilson Respond to[...]

Healthcare

Lenz Therapeutics Inc.

10/08/2025 | Press release | Distributed by Public on 10/08/2025 14:41

Material Event (Form 8-K)

Item 8.01 Other Events.

On October 7, 2025, the Company sold 1,748,634 shares of common stock at a purchase price of $45.75 per share for gross proceeds of approximately $80,000,000 in a block trade to a single investor under the Company's "at the market" Sales Agreement with TD Securities (USA) LLC, dated as of April 4, 2025 (the "Sales Agreement"). The sale was made pursuant and subject to the terms of the Sales Agreement, a copy of which was filed with the Current Report on Form 8-K filed by the Company on April 4, 2025.

Lenz Therapeutics Inc. published this content on October 08, 2025, and is solely responsible for the information contained herein. Distributed via SEC EDGAR on October 08, 2025 at 20:41 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]